Purchase Order HT942525P0065
- Not listed
- This is a $1,099,897.03 firm-fixed-price SBIR Phase II contract awarded by the U.S. Army Medical Command (MEDCOM) to FTL Labs Corp, a small business research and development firm. The contract is for the development of the SONOPOD, an innovative medical research and development project. As a total small business set-aside, this contract falls under the Small Business Innovation Research (SBIR) program, which aims to stimulate technological innovation and commercialization. FTL Labs Corp has a...
- This federal contract award, W911QY23P0011, was made by the U.S. Army Research, Development and Engineering Command (RDECOM) to FTL Labs Corporation, a small business, under the Small Business Innovation Research (SBIR) program. The $167,395.88 firm fixed-price purchase order is for Phase I research and development work on proposal A222-015-0138, with a planned completion date of October 22, 2023. FTL Labs is an experienced SBIR contractor, having received over 30 SBIR Phase I and II awards from...
- This is a firm fixed price contract awarded by the Department of the Army Medical Command to FTL Labs Corporation, a small business, for the "Sensorized Prosthetic Alignment Readout (SPARO)" research and development project. The contract, valued at $149,989.05, is part of the Small Business Innovation Research (SBIR) program and is designated as a total small business set-aside. FTL Labs provides research and development services to U.S. federal government agencies, with a focus on...
- The U.S. Air Force Research Laboratory (AFRL) awarded a $74,959 firm fixed-price purchase order to Rizlab Health Inc., a small business, to develop a wireless portable electronic hematology analyzer for infection and sepsis stratification on the battlefield. This Phase I SBIR contract supports Rizlab's research into rapid diagnostic technologies, particularly portable blood count analyzers. Rizlab has received multiple awards from federal agencies like the Department of Health and Human Services...
- The Defense Health Agency has awarded a $1.3 million Phase II Small Business Innovation Research (SBIR) contract to Luna Labs USA LLC, a Charlottesville, Virginia-based small business specializing in advanced materials and sensing technologies. The contract, awarded March 25, 2024, with completion targeted for July 24, 2026, supports research and development of modular stabilization technology for whole blood components intended for reconstitution and transfusion at the point of injury. This...
- This is a $149,991.30 firm fixed price contract awarded by the Department of the Army Medical Command to FTL Labs Corporation, a small business, under the Small Business Innovation Research (SBIR) program. The contract is for Phase I research and development of a compact speaker array for clinical testing of ear-level devices. FTL Labs is an experienced federal contractor, having received over 20 prime contracts from the Department of Defense, including SBIR awards and other research and...
- <p>The Defense Health Agency awarded a $249,586.92 Small Business Innovation Research (SBIR) Phase I purchase order to Caizio LLC, a for-profit limited liability company located in Irving, Texas. The contract is for the development of a "Handheld Mechano-Optical Platelet Force Sensing Device", a medical research and development effort. The contract has a completion date of January 2, 2026 and is set aside for small businesses.</p>
- The Defense Health Agency awarded a $249,224.38 Small Business Innovation Research (SBIR) Phase I purchase order to SPZ Technologie LLC for the development of a Platelet Contractility Imaging Analyzer (PCIA). This medical research and development contract is designated as a Total Small Business set-aside and carries a firm fixed-price structure, with an ultimate completion date of January 2, 2026. The work will be performed in Los Angeles, California. The SBIR Phase I program, administered by...
- This is a federal contract award from the Naval Facilities Engineering Command (NAVFAC), a defense agency, to FTL Labs Corp, a small business research and development firm located in Amherst, Massachusetts. The contract is for a Small Business Innovation Research (SBIR) Program Phase II project, with a ceiling value of $991,593.00 and a period of performance through January 23, 2026. The contract is designated as a total small business set-aside, reflecting FTL Labs Corp's expertise in...
- The Department of the Army Medical Command awarded a $499,998.25 Definitive Contract to Hemosonics, LLC, a small business, to provide a point-of-care device for the diagnosis of platelet injury in trauma patients. This contract is part of the Small Business Innovation Research (SBIR) Program Phase II and is set aside for Total Small Businesses. Hemosonics, LLC specializes in providing medical equipment, particularly blood and hemostasis analyzers, to various government agencies, with the...
The Defense Health Agency has awarded a $249,980.33 firm fixed-price purchase order to FTL Labs Corp, a small business specializing in research and development based in Amherst, Massachusetts. This Small Business Innovation Research (SBIR) Program Phase I award is designated as a total small business set-aside and involves the development of the HemoSight Functional Platelet Evaluation Kit. The contract is expected to reach completion by January 2, 2026, with work performed at FTL Labs Corp's Amherst facility. FTL Labs Corp brings substantial experience in federal contracting and SBIR research to this initiative, with a proven track record of securing defense and medical research contracts from agencies including the Naval Sea Systems Command, Naval Air Warfare Center, Air Force Research Laboratory, DARPA, and the U.S. Army Medical Command. The HemoSight platform represents an advancement in medical diagnostic technology aligned with the Defense Health Agency's mission to support military medicine and personnel health readiness. The SBIR Phase I mechanism enables the company to conduct exploratory research on the technical merit and feasibility of this platelet evaluation system before potential progression to Phase II development and commercialization.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $250.0k | 6/3/25 |